COT-17 EFFECT OF BEVACIZUMAB AGAINST CYSTIC COMPONENT OF PRIMARY/METASTATIC BRAIN TUMORS

BACKGROUND: Bevacizumab (BEV) improves the symptom via reducing the peritumoral edema and sometimes via reducing the size of brain tumor. However,the effect of BEV against cystic part of brain tumor has not been documented yet. In this report,we investigated the effect of BEV on cystic component of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Fumiyuki, Takano, Motoki, Yonezawa, Ushio, Taguchi, Akira, Onishi, Shumpei, Kurisu, Kaoru, Sugiyama, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213219/
http://dx.doi.org/10.1093/noajnl/vdz039.197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213219/
http://dx.doi.org/10.1093/noajnl/vdz039.197

Ejemplares similares